Comparison
10p13 P14 Deletion Syndrome Cn379618 vs 17 20 Lyase Deficiency Isolated Included CN372394
Clinical comparison between 10p13 P14 Deletion Syndrome CN379618 and 17 20 Lyase Deficiency Isolated Included CN372394 for differential diagnosis and treatment planning.
10p13 P14 Deletion Syndrome Cn379618
A rare chromosomal disorder caused by deletion of genetic material on chromosome 10. It can affect development, facial features, and organ function. Management involves multidisciplinary care to address specific symptoms and provide developmental support.
17 20 Lyase Deficiency Isolated Included CN372394
6 comparison axes
Onset
10p13 P14 Deletion Syndrome Cn379618
0-0
17 20 Lyase Deficiency Isolated Included CN372394
0-16
Onset patterns differ
Severity
10p13 P14 Deletion Syndrome Cn379618
severe
17 20 Lyase Deficiency Isolated Included CN372394
severe
Different severity levels
Chronic
10p13 P14 Deletion Syndrome Cn379618
Chronic
17 20 Lyase Deficiency Isolated Included CN372394
Chronic
Differing course
Communicable
10p13 P14 Deletion Syndrome Cn379618
No
17 20 Lyase Deficiency Isolated Included CN372394
No
Different transmission
Body System
10p13 P14 Deletion Syndrome Cn379618
congenital
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Same/different system
Category
10p13 P14 Deletion Syndrome Cn379618
genetic
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Different category
Bottom line
10p13-p14-deletion-syndrome-CN379618 and 17-20-lyase-deficiency-isolated-included-CN372394 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 10p13 P14 Deletion Syndrome Cn379618 | 17 20 Lyase Deficiency Isolated Included CN372394 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Congenital developmental differences may be evident from birth. | Features related to sex-hormone production may appear from infancy through adolescence. | Moderate |
| Main clinical domain | May involve multiple congenital systems, including development and organ function. | Primarily concerns endocrine steroid synthesis; broader features are not established here. | High |
| Etiology | Deletion of genetic material at chromosome 10p13-p14. | Isolated 17,20-lyase deficiency; the supplied source does not establish its molecular details. | High |
When to favor each condition
Choose 10p13 P14 Deletion Syndrome Cn379618 when
Congenital multisystem findings
A chromosomal deletion better fits developmental, facial, or organ differences beginning at birth.
Moderate
Abnormal chromosomal study
A confirmed 10p13-p14 deletion supports this diagnosis over an enzyme deficiency.
High
Need for developmental support
Management centers on symptom-specific multidisciplinary and developmental care.
Moderate
Choose 17 20 Lyase Deficiency Isolated Included CN372394 when
Suspected steroid-pathway disorder
Endocrine evaluation is more relevant when sex-hormone synthesis is the main concern.
Moderate
Presentation during childhood or puberty
The listed onset extends to age 16, unlike the birth-limited left onset.
Low
Normal chromosomal deletion testing
Absence of the deletion does not prove this diagnosis; targeted endocrine assessment is needed.
Moderate
How key tests differ
| Test | 10p13 P14 Deletion Syndrome Cn379618 | 17 20 Lyase Deficiency Isolated Included CN372394 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify deletion involving 10p13-p14. | Not expected to establish isolated lyase deficiency. | A deletion supports the left condition but does not exclude a separate endocrine disorder. |
| Steroid hormone profile | No characteristic pattern is established by the source. | Abnormal sex-steroid results may suggest, but not alone diagnose, lyase deficiency. | Interpret results with clinical context; no cutoff is supplied. |
| Developmental and dysmorphology assessment | May document congenital developmental or structural findings. | Such findings are not established as characteristic here. | Assessment guides support needs but is not diagnostic by itself. |
Prognosis comparison
10p13 P14 Deletion Syndrome Cn379618
- Outcome
- Potentially severe and chronic, but individual outcome is not established.
- Factors
- Extent of deletion and affected development or organs may influence needs.
17 20 Lyase Deficiency Isolated Included CN372394
- Outcome
- Listed as severe and chronic, although source details are insufficient.
- Factors
- Endocrine findings and age at recognition may matter; specifics are not established.
Time frame: Left onset is listed at birth; right onset may range from birth to age 16.
Prognosis should be individualized; mortality and exact outcomes are not supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | May require long-term developmental support. Not established from the supplied description. Severity and specific deficits vary and need individual assessment. |
| Organ or structural complications | Organ function may be affected, but exact complications are not specified. No organ-complication pattern is established in the source. Do not infer a specific complication without clinical evidence. |
| Endocrine or pubertal complications | Not established as a defining feature. Disordered sex-hormone production may affect pubertal development. Hormone abnormalities are findings requiring specialist interpretation. |
Patient education highlights
- HighDifferent causes
One is a chromosomal deletion; the other is an endocrine enzyme deficiency. Neither is communicable.
- HighTests are not diagnoses
An abnormal chromosome or hormone result needs clinician interpretation and confirmatory assessment.
- MediumIndividualized care
Care depends on confirmed findings. No dose, cutoff, or outcome can be generalized from these sparse data.